Skip to main content
. 2020 Sep 8;11:552102. doi: 10.3389/fphar.2020.552102

Table 2B.

Utilization of certain proton pump inhibitors (PPIs’) over the last 5 years in Hungary (organized in descending order based on the data from 2018)—defined daily dose (DDD) per 1,000 inhabitants and per day.

ATC Active Ingredient DDD per 1,000 inhabitants and per day (share in %) trend
2014 2015 2016 2017 2018
A02BC02 pantoprazole 21.06 25.78 28.03 29.36 30.04 graphic file with name fphar-11-552102-g007.jpg
(50.27) (54.41) (56.87) (57.62) (59.64)
A02BC05 esomeprazole 9.33 10.33 10.60 11.21 11.04 graphic file with name fphar-11-552102-g008.jpg
(22.28) (21.80) (21.5) (21.99) (21.91)
A02BC04 rabeprazole 5.54 5.38 5.12 5.00 4.42 graphic file with name fphar-11-552102-g009.jpg
(13.22) (11.36) (10.40) (9.82) (8.77)
A02BC03 lansoprazole 4.36 4.08 3.78 3.51 2.97 graphic file with name fphar-11-552102-g0010.jpg
(10.41) (8.61) (7.67) (6.88) (5.89)
A02BC01 omeprazole 1.60 1.81 1.75 1.88 1.91 graphic file with name fphar-11-552102-g0011.jpg
(3.82) (3.82) (3.55) (3.69) (3.79)
All PPIs (A02AB) 41.88 47.37 49.29 50.96 50.37 graphic file with name fphar-11-552102-g0012.jpg
(100.00) (100.00) (100.00) (100.00) (100.00)